Tarsus Pharmaceuticals, Inc. short interest in 2025
In 2025, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 18.36% of shares outstanding on 15 Jan 2025 to 10.72% on 31 Dec 2025, a change of -7.64 percentage points. The year's high was 21.92% on 15 Apr 2025 and its low 10.72% on 31 Dec 2025, averaging 18.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.09 days on 28 Nov 2025. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.36% (15 Jan 2025)
- End of year
- 10.72% (31 Dec 2025)
- Change
- -7.64 pp
- High
- 21.92% (15 Apr 2025)
- Low
- 10.72% (31 Dec 2025)
- Average
- 18.19%
- Highest days to cover
- 17.09 (28 Nov 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.36% | 7.06 | |
| 31 Jan 2025 | 19.20% | 15.93 | |
| 14 Feb 2025 | 18.53% | 15.59 | |
| 28 Feb 2025 | 19.21% | 9.28 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 19.37% | 12.47 | |
| 31 Mar 2025 | 20.01% | 10.48 | |
| 15 Apr 2025 | 21.92% | 12.09 | |
| 30 Apr 2025 | 19.78% | 12.67 | |
| 15 May 2025 | 18.52% | 8.91 | 10-Q filed, results (8-K) |
| 30 May 2025 | 19.22% | 16.68 | |
| 13 Jun 2025 | 19.31% | 14.70 | |
| 30 Jun 2025 | 21.08% | 13.73 | |
| 15 Jul 2025 | 19.54% | 14.57 | |
| 31 Jul 2025 | 19.28% | 14.50 | |
| 15 Aug 2025 | 17.39% | 9.14 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 16.41% | 12.99 | |
| 15 Sep 2025 | 18.08% | 9.17 | |
| 30 Sep 2025 | 17.16% | 11.37 | |
| 15 Oct 2025 | 16.64% | 10.14 | |
| 31 Oct 2025 | 17.15% | 14.89 | |
| 14 Nov 2025 | 16.88% | 14.61 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 16.77% | 17.09 | |
| 15 Dec 2025 | 16.04% | 15.00 | |
| 31 Dec 2025 | 10.72% | 5.59 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.